AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
A phase 2 trial of Sonesitatug vedotin, FLOT, FOLFIRI in pancreatic ductal adenocarcinoma, run by AstraZeneca, now recruiting.
Overview
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 is a phase 2 interventional study registered as NCT06219941 by AstraZeneca, with 226 participants planned, started 2023-12-13 and due to reach its primary completion in 2026-11-17. Interventions recorded: AZD0901, 5-Fluorouracil, Leucovorin, l-leucovorin, Irinotecan. Conditions listed: Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Shares Irinotecan (and liposomal irinotecan), FOLFIRI (5-FU, leucovorin, irinotecan), Gemcitabine, Pancreatic ductal adenocarcinoma.
- TrialA Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), AstraZeneca.
- TrialStudy of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-muta
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), Gemcitabine, Pancreatic ductal adenocarcinoma.
- TrialHSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel).
- TrialStudy of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer
- TrialIntra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- TrialEvaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer
- TrialClinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer